Koshinski Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.01M | Buy |
7,983
+602
| +8% | +$79.3K | 0.05% | 300 |
|
|
2026
Q1 | $1.03M | Buy |
7,381
+1,313
| +22% | +$184K | 0.06% | 276 |
|
|
2025
Q4 | $745K | Buy |
6,068
+355
| +6% | +$43.1K | 0.05% | 330 |
|
|
2025
Q3 | $634K | Buy |
5,713
+2,055
| +56% | +$234K | 0.04% | 364 |
|
|
2025
Q2 | $406K | Sell |
3,658
-692
| -16% | -$73.6K | 0.03% | 447 |
|
|
2025
Q1 | $487K | Buy |
4,350
+836
| +24% | +$86.3K | 0.04% | 384 |
|
|
2024
Q4 | $325M | Sell |
3,514
-101
| -3% | -$9.09K | 0.03% | 464 |
|
|
2024
Q3 | $303K | Buy |
3,615
+259
| +8% | +$19.8K | 0.03% | 487 |
|
|
2024
Q2 | $227K | Buy |
3,356
+398
| +13% | +$26.6K | 0.02% | 538 |
|
|
2024
Q1 | $217K | Buy |
+2,958
| New | +$227K | 0.02% | 521 |
|
|
2023
Q4 | – | Sell |
-2,975
| Closed | -$223K | – | 551 |
|
|
2023
Q3 | $223K | Buy |
2,975
+145
| +5% | +$11.2K | 0.03% | 497 |
|
|
2023
Q2 | $218K | Sell |
2,830
-677
| -19% | -$54K | 0.02% | 533 |
|
|
2023
Q1 | $291K | Sell |
3,507
-254
| -7% | -$21K | 0.03% | 427 |
|
|
2022
Q4 | $323K | Sell |
3,761
-1,206
| -24% | -$95.5K | 0.03% | 445 |
|
|
2022
Q3 | $306K | Buy |
4,967
+804
| +19% | +$50.7K | 0.04% | 412 |
|
|
2022
Q2 | $257K | Sell |
4,163
-650
| -14% | -$40.2K | 0.03% | 494 |
|
|
2022
Q1 | $286K | Buy |
4,813
+1
| +0% | +$64 | 0.02% | 489 |
|
|
2021
Q4 | $349K | Sell |
4,812
-74
| -2% | -$5.1K | 0.03% | 480 |
|
|
2021
Q3 | $341K | Buy |
4,886
+403
| +9% | +$28.3K | 0.03% | 474 |
|
|
2021
Q2 | $309K | Sell |
4,483
-1,586
| -26% | -$106K | 0.04% | 426 |
|
|
2021
Q1 | $392K | Sell |
6,069
-3,041
| -33% | -$196K | 0.04% | 411 |
|
|
2020
Q4 | $530K | Buy |
9,110
+4,457
| +96% | +$269K | 0.07% | 303 |
|
|
2020
Q3 | $300 | Sell |
4,653
-1,247
| -21% | -$86.5K | 0.04% | 391 |
|
|
2020
Q2 | $454K | Buy |
5,900
+957
| +19% | +$73.3K | 0.07% | 296 |
|
|
2020
Q1 | $370K | Buy |
+4,943
| New | +$342K | 0.08% | 297 |
|
|
2019
Q2 | – | Sell |
-3,409
| Closed | -$222 | – | 301 |
|
|
2019
Q1 | $222 | Sell |
3,409
-2,874
| -46% | -$191K | 0.06% | 346 |
|
|
2018
Q4 | $393K | Sell |
6,283
-4,322
| -41% | -$302K | 0.1% | 254 |
|
|
2018
Q3 | $819K | Buy |
10,605
+4,793
| +82% | +$362K | 0.12% | 231 |
|
|
2018
Q2 | $412K | Sell |
5,812
-552
| -9% | -$39K | 0.13% | 236 |
|
|
2018
Q1 | $480K | Sell |
6,364
-1,609
| -20% | -$128K | 0.15% | 214 |
|
|
2017
Q4 | $571K | Sell |
7,973
-280
| -3% | -$21.3K | 0.14% | 232 |
|
|
2017
Q3 | $669K | Buy |
8,253
+440
| +6% | +$33.6K | 0.22% | 148 |
|
|
2017
Q2 | $553K | Buy |
7,813
+4,033
| +107% | +$268K | 0.2% | 169 |
|
|
2017
Q1 | $257K | Sell |
3,780
-1,435
| -28% | -$101K | 0.1% | 263 |
|
|
2016
Q4 | $416K | Sell |
5,215
-3,760
| -42% | -$279K | 0.21% | 158 |
|
|
2016
Q3 | $710K | Buy |
8,975
+345
| +4% | +$28K | 0.35% | 95 |
|
|
2016
Q2 | $720K | Buy |
8,630
+1,462
| +20% | +$130K | 0.39% | 91 |
|
|
2016
Q1 | $683K | Buy |
7,168
+1,392
| +24% | +$126K | 0.44% | 80 |
|
|
2015
Q4 | $584K | Sell |
5,776
-214
| -4% | -$22.3K | 0.41% | 75 |
|
|
2015
Q3 | $701K | Buy |
5,990
+1,158
| +24% | +$129K | 0.45% | 59 |
|
|
2015
Q2 | $566K | Buy |
4,832
+1,406
| +41% | +$154K | 0.36% | 85 |
|
|
2015
Q1 | $336K | Buy |
3,426
+1,256
| +58% | +$128K | 0.22% | 141 |
|
|
2014
Q4 | $205K | Buy |
+2,170
| New | +$224K | 0.12% | 220 |
|
Other funds holding GILD
Koshinski Asset Management's GILD Position: Q2 2026 in Review
Koshinski Asset Management increased its Gilead Sciences (GILD) stake by 8.2% in Q2 2026, buying an estimated $79.3K and bringing the position to 7,983 shares worth $1.01M. The position accounts for 0.05% of the portfolio, ranked #300.
Koshinski Asset Management first reported a position in GILD in Q4 2014 and has held it in 43 quarters since. The position peaked at $325M in Q4 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Koshinski Asset Management held 7,983 shares of Gilead Sciences worth $1.01M as of Q2 2026.
- Koshinski Asset Management bought 602 Gilead Sciences shares in Q2 2026, an estimated $79.3K.
- Gilead Sciences made up 0.05% of Koshinski Asset Management's portfolio in Q2 2026, its #300 holding.
- Koshinski Asset Management first reported a position in Gilead Sciences in Q4 2014 and has held it in 43 quarters since.
- Koshinski Asset Management's Gilead Sciences position peaked at $325M in Q4 2024.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.